References
- Bauer S, Groh V, Wu J, et al (1999). Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science, 285, 727-9. https://doi.org/10.1126/science.285.5428.727
- Busche A, Goldmann T, Naumann U, et al (2006). Natural killer cell-mediated rejection of experimental human lung cancer by genetic overexpression of major histocompatibility complex class I chain-related gene A. Hum Gene Ther, 17, 135-46. https://doi.org/10.1089/hum.2006.17.135
- Cohen HT and McGovern FJ (2005). Renal-cell carcinoma. N Engl J Med, 353, 2477-90. https://doi.org/10.1056/NEJMra043172
- Diefenbach A, Jensen ER, Jamieson AM, Raulet DH (2001). Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature, 413, 165-71. https://doi.org/10.1038/35093109
- Diefenbach A and Raulet DH (2002). The innate immune response to tumors and its role in the induction of T-cell immunity. Immunol Rev, 188, 9-21. https://doi.org/10.1034/j.1600-065X.2002.18802.x
- Doubrovina ES, Doubrovin MM, Vider E (2003). Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma. J Immunol, 171, 6891-9. https://doi.org/10.4049/jimmunol.171.12.6891
- Herberman RB, Nunn ME, Lavrin DH (1975). Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer, 16, 216-29. https://doi.org/10.1002/ijc.2910160204
- Mrozek E, Anderson P, Caligiuri MA (1996). Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood, 87, 2632-40.
- Pardoll DM (2001). Immunology. Stress, NK receptors, and immune surveillance. Science, 294, 534-6. https://doi.org/10.1126/science.1066284
- Raffaghello L, Prigione I, Airoldi I, et al (2004). Down regulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma. Neoplasia, 6, 558-68. https://doi.org/10.1593/neo.04316
- Sconocchia G, Spagnoli GC, Del Principe D, et al (2009). Defective infiltration of natural killer cells in MICA/Bpositive renal cell carcinoma involves beta (2)-integrinmediated interaction. Neoplasia, 11, 662-71. https://doi.org/10.1593/neo.09296
- Weissinger D, Tagscherer KE, Macher-Goppinger S, et al (2013). The soluble Decoy receptor 3 is regulated by a PI3Kdependent mechanism and promotes migration and invasion in renal cell carcinoma. Mol Cancer, 12, 120. https://doi.org/10.1186/1476-4598-12-120
- Wu JD, Higgins LM, Steinle A, et al (2004). Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer. J Clin Invest, 114, 560-8. https://doi.org/10.1172/JCI200422206
- Yang F, Shao Y, Yang F, et al (2013). Valproic acid upregulates NKG2D ligand expression and enhances susceptibility of human renal carcinoma cells to NK cell-mediated cytotoxicity. Arch Med Sci, 9, 323-31.
- Ye YB, Zhou ZF, Chen Q, et al (2008). The roles of soluble MICA in immune escape of breast tumor. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 24, 904-8 (Article in Chinese).
Cited by
- Epidemiology and Trends in Incidence of Kidney Cancer in Iran vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.5859
- Regulation Roles of MICA and NKG2D in Human Renal Cancer Cells vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.3901
- The clinical and biological significance of MICA in clear cell renal cell carcinoma patients vol.37, pp.2, 2016, https://doi.org/10.1007/s13277-015-4041-7
- Identification of genes associated with renal cell carcinoma using gene expression profiling analysis vol.12, pp.1, 2016, https://doi.org/10.3892/ol.2016.4573